These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 11106655
1. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. Chen RL, Lander AD. J Biol Chem; 2001 Mar 09; 276(10):7507-17. PubMed ID: 11106655 [Abstract] [Full Text] [Related]
2. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis. Doege K, Chen X, Cornuet PK, Hassell J. Matrix Biol; 1997 Oct 09; 16(4):211-21. PubMed ID: 9402011 [Abstract] [Full Text] [Related]
3. Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. Winzen U, Cole GJ, Halfter W. J Biol Chem; 2003 Aug 08; 278(32):30106-14. PubMed ID: 12773545 [Abstract] [Full Text] [Related]
4. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. Zhang L, David G, Esko JD. J Biol Chem; 1995 Nov 10; 270(45):27127-35. PubMed ID: 7592967 [Abstract] [Full Text] [Related]
5. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. Kokenyesi R, Bernfield M. J Biol Chem; 1994 Apr 22; 269(16):12304-9. PubMed ID: 8163535 [Abstract] [Full Text] [Related]
6. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. Dolan M, Horchar T, Rigatti B, Hassell JR. J Biol Chem; 1997 Feb 14; 272(7):4316-22. PubMed ID: 9020150 [Abstract] [Full Text] [Related]
8. Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1. Svensson G, Awad W, Håkansson M, Mani K, Logan DT. J Biol Chem; 2012 Apr 20; 287(17):14040-51. PubMed ID: 22351761 [Abstract] [Full Text] [Related]
9. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. Kokenyesi R, Silbert JE. Biochem Biophys Res Commun; 1995 Jun 06; 211(1):262-7. PubMed ID: 7779094 [Abstract] [Full Text] [Related]
10. Tenascin-contactin/F11 interactions: a clue for a developmental role? Vaughan L, Weber P, D'Alessandri L, Zisch AH, Winterhalter KH. Perspect Dev Neurobiol; 1994 Jun 06; 2(1):43-52. PubMed ID: 7530143 [Abstract] [Full Text] [Related]
11. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, Meyer TN, Schwesinger C, Bai X, Esko JD, Nigam SK. Dev Biol; 2004 Aug 15; 272(2):310-27. PubMed ID: 15282150 [Abstract] [Full Text] [Related]
12. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content. Mertens G, Van der Schueren B, van den Berghe H, David G. J Cell Biol; 1996 Feb 15; 132(3):487-97. PubMed ID: 8636224 [Abstract] [Full Text] [Related]
13. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. Zhang L, Esko JD. J Biol Chem; 1994 Jul 29; 269(30):19295-9. PubMed ID: 8034692 [Abstract] [Full Text] [Related]
14. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. Litwack ED, Stipp CS, Kumbasar A, Lander AD. J Neurosci; 1994 Jun 29; 14(6):3713-24. PubMed ID: 8207484 [Abstract] [Full Text] [Related]
15. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. Herndon ME, Stipp CS, Lander AD. Glycobiology; 1999 Feb 29; 9(2):143-55. PubMed ID: 9949192 [Abstract] [Full Text] [Related]
16. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. Lories V, Cassiman JJ, Van den Berghe H, David G. J Biol Chem; 1992 Jan 15; 267(2):1116-22. PubMed ID: 1339431 [Abstract] [Full Text] [Related]
17. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains. Graham LD, Whitelock JM, Underwood PA. Biochem Biophys Res Commun; 1999 Mar 24; 256(3):542-8. PubMed ID: 10080934 [Abstract] [Full Text] [Related]
18. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Tapanadechopone P, Hassell JR, Rigatti B, Couchman JR. Biochem Biophys Res Commun; 1999 Nov 30; 265(3):680-90. PubMed ID: 10600481 [Abstract] [Full Text] [Related]
19. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. French MM, Gomes RR, Timpl R, Höök M, Czymmek K, Farach-Carson MC, Carson DD. J Bone Miner Res; 2002 Jan 30; 17(1):48-55. PubMed ID: 11771669 [Abstract] [Full Text] [Related]
20. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. Watanabe K, Yamada H, Yamaguchi Y. J Cell Biol; 1995 Sep 30; 130(5):1207-18. PubMed ID: 7657705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]